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        The mystery of oral tolerance 
  Oral tolerance has been on the minds 
of people even before rational ap-
proaches to immunity. Every now and 
then, someone realized that eating 
certain substances could reduce their 
otherwise   “  toxic  ”   impact on the body. 
As an example, the swallowing of hair 
dyes by aging men was claimed to in-
terfere with their allergizing properties, 
thereby permitting less painful   “  reju-
venation.  ”   In the immunology world, 
oral tolerance after enteral uptake of 
antigen became known as   “  immuno-
logic unresponsiveness.  ”   Special antigen-
presenting cells in the gut were held 
responsible for inducing oral tolerance, 
and local generation of   “  suppressor  ”   
cells was raised as a possible mechanism 
(  1  ). Such extrapolations, however, were 
not free of controversy, which may 
have to do with diff  erent guts of dif-
ferent individuals. It seems, however, 
that the times of   “  gut feelings  ”   are 
over, as scientifi  c evidence now sheds 
new light on the mystery of oral toler-
ance. Three new papers demystify oral 
tolerance by showing that RA made 
by gut-associated DCs enhances the 
conversion of T cells into T reg cells 
(see Coombes et al. [  2  ] on p. 1757 of 
this issue; Sun et al. [  3  ] on p. 1775 of 
this issue; and Benson et al. [  4  ] on 
p. 1765 of this issue). 
  Gut-associated lymphoid tissue (GALT) 
  The GALT consists of lymphoid cells 
in Peyer  ’  s patches, mesenteric lymph 
nodes, lamina propria, and gut epithe-
lium. In GALT, DCs in both the 
Peyer  ’  s patches and mesenteric lymph 
nodes exhibit a unique CD103 
  , CD8 
     , 
CD11b 
   phenotype. It was initially 
demonstrated that recognition of anti-
gen on the surface of these DCs by 
lymphocytes made the lymphocytes re-
turn to the gut (  5  ). This process is me-
diated by the DC-induced expression 
of the     4    7 integrin on lymphocytes, 
which then binds to the mucosal ad-
dressin cell adhesion molecule on blood 
vessels in the gut (  6  ). These lympho-
cytes also express CC chemokine re-
ceptor (CCR) 9, which binds to the 
thymus-expressed chemokine ligand on 
epithelial cells in the crypts of the 
small intestine (  7  ). Subsequently, it was 
discovered that the vitamin A metab-
olite RA was responsible for the up-
regulation of the     4    7 integrin and 
CCR9. The CD103 
 , gut-associated 
DCs express relatively high levels of 
retinal dehydrogenases, the enzymes 
required for the irreversible genera-
tion of RA from vitamin A (retinal). 
Inhibiting these enzymes reduced the 
expression of the     4    7 integrin on T 
cells and resulted in their depletion 
from the intestinal lamina propria (  8  ). 
These results explained why T cells 
stimulated by antigen on gut-associated 
DCs return to GALT. 
  T reg cells 
  T reg cells have been postulated to play 
an important role in oral tolerance. 
Research on this cell type has been on 
the upswing since specifi  c markers be-
came available that allow these cells 
to be distinguished from other T cells; 
among these markers are the      chain of 
the high affi   nity interleukin (IL) 2 re-
ceptor (CD25) on the cell surface and 
the transcription factor FoxP3. FoxP3 
is essential for the generation and func-
tion of certain T reg cells, which pre-
vent deadly autoimmune disease by 
suppressing eff  ector T cells (  9  ). T reg 
cells can be generated intrathymically 
upon confrontation with T cell recep-
tor agonist ligands expressed by thymic 
epithelial cells (  10  ). This process does 
not require TGF-     or intact TGF-     
signaling in developing T cells but 
is dependent on co-stimulation by the 
CD28 receptor. The generation of 
Foxp3-expressing T reg cells is not re-
stricted to the thymus, however, as for-
mation of these cells can be induced 
in peripheral lymphoid tissue (  11, 12  ). 
In this case, the modalities of T reg cell 
induction are diff  erent from those in 
the thymus. It was found that generation 
of T reg cells in peripheral lymphoid 
organs required antigen presentation in 
the absence of co-stimulation (i.e., anti-
gen presentation under subimmuno-
genic conditions) ( 11, 12 ). Furthermore, 
the conversion of naive T cells into T 
reg cells was shown to require intact 
TGF-     signaling in the T cells, indicat-
ing an obligatory role for TGF-     in 
this process (  12  ). These results contrast 
somewhat with experimental condi-
tions that induce T reg cell conversion 
in vitro (  13  )  —  stimulation with CD3 
and CD28 antibodies in the presence 
of TGF-    . This particular protocol of 
inducing conversion in the presence 
of CD28 antibodies may be responsible 
for the apparent instability of Foxp3 
expression by in vitro  –  converted cells 
(  14  ), whereas Foxp3 expression of in 
vivo  –  converted cells is more stable 
(  11, 12  ). The results from Benson et al. 
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rating a gut-specifi  c mechanism of RA-
enhanced, TGF-     –  dependent conversion 
of T cells into T reg cells     (  Fig. 1  ).   It re-
mains to be seen whether this type of 
conversion induced by CD103 
   DCs in 
GALT represents the sole mechanism 
involved in oral tolerance. 
  RA binds to nuclear RA receptors 
(RARs) that regulate genes both di-
rectly and indirectly. RAR     contains 
an RA-responsive element in its pro-
moter, which upon RA binding in-
duces more RAR     expression (  15  ). 
Interestingly, RAR ligation can inhibit 
the transcriptional activity of activating 
protein  –  1 (AP-1), a dimeric transcrip-
tion factor that, in mammals, consists 
mostly of Jun and Fos proteins, perhaps 
by a direct protein  –  protein interaction 
with c-Jun (  16  ). AP-1 is induced through 
co-stimulation of T cells and regulates 
gene expression of, for instance, the 
IL-2 gene in a DNA binding complex 
with nuclear factor of activated T cells 
(NFAT;   Fig. 2  ).   It has recently been 
shown that Foxp3 also regulates gene 
expression in a DNA binding complex 
with NFAT (  17, 18  ) and that AP-1 can 
interfere with the formation of the 
Foxp3  –  NFAT complex (  17  ). How co-
stimulation interferes with conversion of 
T cells into T reg cells is presently un-
known. AP-1 may interfere with stable 
Foxp3 expression that is induced by TCR 
signals and by TGF-     and may involve 
a Foxp3-dependent autoregulatory loop. 
RA will in turn interfere with the neg-
ative eff  ect of co-stimulation in this 
process by inhibiting the action of AP-1 
(  Fig. 2  ). In fact, this might be the sole 
mechanism by which RA enhances TGF-
      –  dependent conversion of T cells into 
T reg cells. 
  It is of interest to note that Ito cells 
in the liver are a major storage place 
for vitamin A in the body. It is, how-
ever, not known whether these cells 
can metabolize vitamin A into RA. If 
so, these cells could also be involved 
in the conversion of naive T cells into 
T reg cells, even though a recent study 
suggested more of an immunogenic 
than a suppressive role for these cells 
(  19  ). Yet, this study does not strictly 
rule out a role for Ito cells in T reg 
cell conversion. 
also show that RA interferes, at least par-
tially, with the negative impact of co-
stimulation in the conversion process (  4  ). 
  Finally, Foxp3 expression induced 
in T reg cells by RA and TGF-     ap-
peared stable in vitro (  2  –  4  ) but less sta-
ble after antigenic stimulation in vivo 
(  4  ). However, it is somewhat diffi   cult 
to determine whether some of the re-
sults are caused by outgrowth of con-
taminating Foxp3 
      cells rather than the 
instability of Foxp3 expression. 
  In summary, the results of these 
three papers (  2  –  4  ) show that CD103 
   
DCs in GALT are specially equipped 
for converting antigen-specifi  c T cells 
into Foxp3 
   T reg cells in an RA- and 
TGF-      –  dependent manner. The RA-
enhanced conversion process also leads to 
the up-regulation of     4    7 integrin and 
CCR9 permitting the newly formed 
T reg cells to accumulate preferentially 
in GALT. Finally, RA can reduce the 
negative impact of co-stimulation on the 
TGF-      –  dependent conversion of T cells 
into Foxp3 
   T reg cells. 
  Where to go from here? 
  The new experiments lend credibility 
to the notion of oral tolerance by elabo-
actually show that strong co-stimulation 
in vitro is, in fact, also counterproductive 
to TGF-      –  dependent T reg cell con-
version (  4  ). 
  RA and T reg cell conversion in vivo 
and in vitro 
  The new papers by Coombes et al. and 
Sun et al. now show that conversion 
takes place more eff  ectively in GALT 
than in other lymphoid tissues (  2, 3  ) 
and that     1.3% of ovalbumin-specifi  c 
T cells converted into T reg cells when 
mice were given ovalbumin in their 
drinking water (  3  ). These in vivo con-
version rates are rather low compared with 
those seen when antigen is delivered 
systemically via the parenteral route under 
subimmunogenic conditions (i.e., when 
co-stimulation is lacking). Under these 
conditions, 10  –  20% of antigen-specifi  c 
cells convert into T reg cells (  11, 12  ). 
Both Coombes et al. and Sun et al. 
go on to show that antigen-presenting 
CD103 
  , but not CD103 
     , DCs purifi  ed 
from GALT induced the generation of 
Foxp3 
   cells in vitro. The conversion 
induced by CD103 
   cells could be di-
minished by adding inhibitors of retinal 
dehydrogenases, indicating that RA 
produced in CD103 
   DCs contributed 
to the conversion process (  Fig. 1  ) (  2, 3  ). 
According to Coombes et al., this con-
version process also required TGF-    , as 
antibody-mediated inhibition of TGF-     
blocked the CD103 
   DC-induced con-
version     (  2  ). Indeed, RA alone could 
not induce conversion but strongly en-
hanced the TGF-      –  dependent conver-
sion of naive T cells into Foxp3 
   T reg 
cells in vitro (  2  –  4  ). As previously noted 
for conventional T cells, RA was also 
responsible for the up-regulation of the 
    4    7 integrin on the converted T reg 
cells (  2  –  4  ), enabling them to home effi   -
ciently to GALT (  4  ). 
  With regard to the negative role of 
co-stimulation in the conversion pro-
cess that was previously shown in in 
vivo studies (  12  ), it is of interest that 
Benson et al. now show that the TGF-
      –  dependent conversion in vitro be-
comes much less effi   cient  when  the 
T cells are strongly co-stimulated by in-
creasing doses of CD28 antibodies (  4  ). 
The new experiments by Benson et al. 
  Figure 1.     RA promotes the differentiation 
of FoxP3 
   T reg cells in the gut. Antigen 
from the gut lumen gains access to CD103 
  
gut-associated DCs. T cells that recognize antigen 
in the context of DC-produced RA and TGF-    
up-regulate Foxp3 and become T reg cells.     JEM VOL. 204, August 6, 2007  1739
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  It certainly appears useful for the 
clinical application of T reg cells that 
RA, which is readily available, en-
hances the antigen-induced and TGF-
      –    dependent conversion of T cells into 
T reg cells in vitro and in vivo. How-
ever, because of the side eff  ects of RA, 
other RAR agonists may be better 
suited for in vivo experiments. It will 
be important to determine whether RA 
is suitable only for the conversion of 
  Figure 2.     Model of gene regulation that 
leads to the differentiation of T helper type 
17 or T reg cells. TCR stimulation and co-
stimulation of T cells results in NFAT and AP-1 
activation, which form a DNA binding complex 
that regulates gene expression. TGF-     signaling 
results in phosphorylation and nuclear translo-
cation of TGF-    – associated  Smad  proteins,  and 
IL-6 signaling activates Stat3. These signals 
combine to promote differentiation into T 
helper type 17 (Th17) effector cells. In the ab-
sence of co-stimulation and/or the presence of 
RA, AP-1 is not produced. In the absence of IL-6, 
Stat3 is not activated. Without AP-1 and Stat3, 
the cell converts into a Foxp3-expressing T reg 
cell in a TCR and TGF-     signaling-dependent 
manner.   
naive T cells into T reg cells or whether 
it can also be used to convert already 
activated and polarized T cells and, 
thereby, to interfere with unwanted, 
ongoing immune responses. 
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